Literature DB >> 30262631

Effectiveness of transdermal oestradiol and natural micronised progesterone for menopausal symptoms.

Louise R Newson1, Amir Lass2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30262631      PMCID： PMC6146001          DOI： 10.3399/bjgp18X699353

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  6 in total

1.  2016 IMS Recommendations on women's midlife health and menopause hormone therapy.

Authors:  R J Baber; N Panay; A Fenton
Journal:  Climacteric       Date:  2016-02-12       Impact factor: 3.005

2.  The impact of micronized progesterone on breast cancer risk: a systematic review.

Authors:  P Stute; L Wildt; J Neulen
Journal:  Climacteric       Date:  2018-01-31       Impact factor: 3.005

Review 3.  Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects.

Authors:  Frank Z Stanczyk; Janet P Hapgood; Sharon Winer; Daniel R Mishell
Journal:  Endocr Rev       Date:  2012-12-13       Impact factor: 19.871

4.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

Review 5.  HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT.

Authors:  M L'Hermite
Journal:  Climacteric       Date:  2013-08       Impact factor: 3.005

6.  Vasomotor symptoms resulting from natural menopause: a systematic review and network meta-analysis of treatment effects from the National Institute for Health and Care Excellence guideline on menopause.

Authors:  G Sarri; H Pedder; S Dias; Y Guo; M A Lumsden
Journal:  BJOG       Date:  2017-05-11       Impact factor: 6.531
  6 in total
  1 in total

1.  The dangers of compounded bioidentical hormone replacement therapy.

Authors:  Louise Newson; Janice Rymer
Journal:  Br J Gen Pract       Date:  2019-10-31       Impact factor: 5.386
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.